Unlike Kt, high Kt/V is associated with greater mortality: The importance of low V

Rafael Pérez-García1, Maite Jaldo1, Roberto Alcázar1

  • 1Servicio de Nefrología, Hospital Universitario Infanta Leonor, Madrid, España.

Nefrologia
|August 5, 2018
PubMed

Insights

Kt/V is not a reliable measure of haemodialysis dose in patients with low body water. Lean mass and serum albumin better predict mortality risk than Kt/V.

Area of Science:

  • Nephrology
  • Dialysis Medicine
  • Clinical Nutrition

Background:

  • Kt/V has historically served as a benchmark for hemodialysis adequacy.
  • Previous studies suggested improved patient survival with higher Kt/V targets.
  • The HEMO study indicated no definitive link between Kt/V and mortality, prompting re-evaluation.

Purpose of the Study:

  • To investigate the relationship between mortality and hemodialysis dose metrics (Kt/V, Kt).
  • To assess the influence of body water content (V) and lean body mass on this relationship.
  • To determine if V confounds the association between Kt/V and mortality.

Main Methods:

  • A cohort of 127 prevalent hemodialysis patients was followed for 36 months.
  • Kt/V, Kt, and Kt/BSA were calculated using ionic dialysance and bioimpedance data.
  • Nutritional parameters, including lean mass index (LMI) and serum albumin, were assessed.

Main Results:

  • Higher Kt/V values correlated with worse survival rates, often linked to lower V and poorer nutrition.
  • Kt/V was found to be less reliable in patients with reduced body water.
  • Lean mass index and serum albumin independently predicted mortality risk and were lower in patients with higher Kt/V and lower V.

Conclusions:

  • Kt/V is not a suitable measure for dialysis dose in patients with low or reduced body water.
  • Kt or Kt/BSA are proposed as more reliable alternatives for assessing hemodialysis adequacy.
  • Nutritional status, particularly lean mass, is a critical factor in predicting mortality in dialysis patients.
Abstract

Related Concept Videos

Drug Distribution: Volume of Distribution01:25

Drug Distribution: Volume of Distribution

The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
Volume of Distribution01:20

Volume of Distribution

The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...